Managing Patients With TR-Related Right Heart Failure and When Should We Intervene?

Topic 2: When is TTVR the Preferred Therapy?

The MonarQ TTVR First-in-Human Experience

TCT 967: Real World Outcomes of Patients With Severe Tricuspid Regurgitation Stratified by Clinical Sequelae

TCT 969: Clinical Outcomes of Patients Unsuitable for Transcatheter Tricuspid Valve Replacement

TCT 970: Cost and Healthcare Utilization by Age, Sex, and Race in the Years Leading Up to a Severe or Clinically Significant Status for Patients With Tricuspid Regurgitation

TCT 972: Short Term Outcomes of Transcatheter Tricuspid Valve Interventions on Post-Procedural Length of Hospital Stay, Readmission for HF and Procedure Success if an Intracardiac Device Is Present

Percutaneous Treatment of Tricuspid Regurgitation with the Novel TriFlO® Device: Technology and Clinical Update

TCT 981: Tricuspid Transcatheter Edge-to-Edge Repair in Heart Transplant Patients: A Single-Center Case Series

TCT 166: Treatment of Complex Tricuspid Valve Leaflet Flail With TTVR: First Successful Case With Trisol Valve